Abiopharma

Wollin Robert J 🟡 adjusted position in 4.4K shares (1 derivative) of MeiraGTx Holdings plc (MGTX) at $7.73 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Naylor Stuart 🟡 adjusted position in 17.6K shares (1 derivative) of MeiraGTx Holdings plc (MGTX) at $7.73 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Giroux Richard 🟡 adjusted position in 28.8K shares (1 derivative) of MeiraGTx Holdings plc (MGTX) at $7.73 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Forbes Alexandria 🟡 adjusted position in 34.1K shares (1 derivative) of MeiraGTx Holdings plc (MGTX) at $7.73 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Exicure HiTron Inc. 🔴 sold 741.3K shares of EXICURE, INC. (XCUR) at $4.50 ($3.3M) Transaction Date: Jan 07, 2026 | Filing ID: 000001

Guyer William 🟡 adjusted position in 20.0K shares (1 derivative) of CORCEPT THERAPEUTICS INC (CORT) at $35.18 ($1.6M) Transaction Date: Jan 06, 2026 | Filing ID: 008023

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Ventyx Biosciences, Inc. (NASDAQ: VTYX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Director AUERBACH ALAN H 🔴 sold 35.0K shares of PUMA BIOTECHNOLOGY, INC. (PBYI) at $5.88 Transaction Date: Jan 06, 2026 | Filing ID: 000924

Johnson & Johnson - Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments

Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments

ROBINS HARLAN S 🔴 sold 10.0K shares of Adaptive Biotechnologies Corp (ADPT) at $16.44 Transaction Date: Jan 06, 2026 | Filing ID: 000001

HUNT DOUGLAS M 🔴 sold 9.0K shares of PUMA BIOTECHNOLOGY, INC. (PBYI) at $5.88 Transaction Date: Jan 06, 2026 | Filing ID: 000922

NOUGUES MAXIMO F 🔴 sold 10.9K shares of PUMA BIOTECHNOLOGY, INC. (PBYI) at $5.88 Transaction Date: Jan 06, 2026 | Filing ID: 000921

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm

📋 Hopkinson Craig C. (Officer) plans to sell 5K shares of Alkermes plc. (at $30.00 each, total $150K) Filed: Jan 08, 2026 | ID: 000028